IT Versione italiana

press conferences » The first international clinical ophthalmological trial concerning treatment of neurotrophic keratitis


Phase I of the clinical trial on the use of recombinant human Nerve Growth Factor

From 07.10.2012 to 07.10.2012    Milano, Hotel Park Hyatt

Press conference by the Dompè Group to announce that it has initiated a Phase I Clinical trial on the use of recombinant human Nerve Growth Factor (rhNGF).  The first results carried out by the Department of Ophthalmology at Campus Biomedico in Rome, have given the first encouraging results now awaiting the outcome of the multicentric trial just underway.




videos

highlights



Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK